Pentose phosphate pathway
Put confidence in GOD and get what
he gives
Put confidence in self and obtained
what you want
Objectives - Gluconeogenesis
• Definition
• Other names
• Occurrence and tissue distribution
• Biomedical importance
• Metabolic pathway
• Clinical correlations
• Regulation
• Difference between EMP and HMP pathway
Definition :
Hexose mono phosphate pathway
• Direct / alternate oxidative pathway for oxidative
decarboxylation of glucose-6-phosphate at C-1,
producing pentose sugars and NADPH + H+
• It is not involved in the generation of energy
Other names for pentose phosphate
pathway
• Hexose monophosphate pathway / shunt
• Phosphogluconate pathway
• Pentose phosphate cycle
• Warburg -Dikens - Lipman pathway
About 10% of glucose / day oxidised by this
pathway
Location of the pathway
• The enzymes of HMP shunt are located in the
cytosol
• Tissue actively participating are
• Liver and Erythrocyte (30%)
• Adipose tissue
• Lactating mammary gland
• Thyroid gland
• Testes and
• Adrenal cortex
• Most of these tissue are involved in fatty acid and
steroid synthesis and depends on NADPH
Overview of the shunt pathway
• It has two phases
• Oxidative phase
• Glucose 6 phosphate is oxidised to generate two
molecules of NADPH with liberation of one CO2
• Non oxidative phase
• Pentose phosphate is converted to intermediates
of glycolysis
Significance of HMP shunt
• It has two main functions – provides
• NADPH
• Pentoses
• These are utilized by other synthetic pathways
Importance of NADPH
• Required for the biosynthesis of fatty acid,
cholesterol, steroids.
• Utilized in synthesis of certain amino acids
involving glutamate dehydrogenase
• Detoxification of drug and foreign compound by
Cyt P450 need NADPH
Importance of NADPH
• Required for the process of phagocytosis
• Essential for maintaining integrity of RBC
membrane and iron in ferrous state
• Required for maintaining glutathione in
reduced form
Importance of Pentoses
• Converts pentose to hexose, tetrose, triose
• Provides glycerol for TAG synthesis
• Important for synthesis of Nucleic acid DNA
& RNA
• Synthesis of Nucleotides –ATP,NAD, FAD,
CoA which acts as coenzymes and energy
1 – Oxidative Phase
Glucose 6 Phosphate
6 Phosphogluconolactone
6 Phosphogluconate
Glucose 6 Phosphate
dehydrogenase
6 Phospho
gluconolactonase
NADP+
NADPH + H+
H2O
Mg+2
• Reducing
equivalent NADPH
are generated
• G6PDH is allosteric
enzyme hence this
is rate limiting step
6 Phosphogluconate
3-Keto-6-Phosphogluconate
D Ribulose 5 Phosphate
6 Phosphogluconate
Dehydrogenase
NADP +
NADP H + H+
CO2
Mg +2
• 3-Keto -6 – Phospho
gluconate is
spontaneously
decrboxylated to
Ribulose 5 phosphate
• C-1 is eliminated as
CO2, One more
NADPH is produced
1 – Oxidative Phase
Phase 2 Non oxidative phase
Inter conversion of pentoses
Ribulose 5 Phosphate Ribulose 5 Phosphate Ribulose 5 Phosphate
Ribose 5 Phosphate Xylulose 5 Phosphate Xylulose 5 Phosphate
Phospho pentose
Isomerase
Phospho pentose
Epimerase
Phospho pentose
Epimerase
3 Ribulose 5 Phosphate
Phase 2 – Non oxidative phase
• In this phase inter conversion of pentose to
triose, tetrose, hexose and heptose takes
place
• Two specific enzymes required
• 1. Transketolase
– ( Thiamine pyrophosphate required as
coenzyme)
• 2. Transaldolase
Xylulose 5
Phosphate
Xylulose 5
PhosphateRibulose 5
Phosphate
Phase 2 -- Non oxidative Steps
conversion of pentoses to hexoses
Glyceraldehyde 3
Phosphate
Sedoheptulose 7
Phosphate
Fructose 6 Phosphate Erythrose 4 Phosphate
Transketolase
Transaldolase
TPP
Glucose 6
Phosphate
Transketolase
Fructose 6 Phosphate
Glyceraldehyde 3
Phosphate
TPP
Glucose 6
Oxidative phase
In short HMP shunt
• When started with six molecules of glucose,
• Gives off 6 CO2 , 12 molecules of NADPH and
5 molecules of glucose regenerated
• Complete oxidation of glucose 6 phosphate
without involvement of mitochondria
Regulation of HMP shunt
• Occurs in 3 ways:
• 1. Ratio of [NADP]/[NADPH] ,
• G6PDH is rate limiting enzyme , it require
NADP hence increase level of NADPH
decreases reaction Insulin activates G6PDH
enzyme
• 2. High carbohydrate increases availability of
glucose and hence increases HMP shunt
and help lipogenesis
• Fasting decreases this pathway
Regulation of HMP shunt
• 3. Insulin and thyroid hormone favours
reaction
• Thus increase BGL increases insulin and
increases HMP reactions
• Insulin favours lipogenesis and uses NADPH
thus increases NADP thereby increases HMP
shunt
Clinical correlations
• Deficiency of Glucose 6 Phosphate
dehydrogenase (G6PDH) leads to
• Haemolytic Anaemia
• Neonatal Jaundice
• Liver cirrhosis
• Kidney failure
G6PDH & Haemolysis
• Due to deficiency of G6PDH, production of NADPH
decreases,
• NADPH is required for keeping Glutathione in its reduced
form
• Reduced Glutathione scavenges Free oxygen radical
(ROS)
• Deficiency leads to accumulation of methemoglobin and
H2O2
• This damages RBC cell membrane and causes Haemolysis
H2O2
H2O
2 GSH
G-S-S-G
Reduced glutathione
Oxidised glutathione
Glutathione peroxidase Glutathione reductase
NADP+
NADPH + H+
Detoxication of hydrogen peroxide and
Maintaining reduced glutathione
G6PDH & Haemolysis
• Most of the patients with G6PD deficiency do not show
any clinical symptoms but develop haemolytic anaemia &
jaundice on exposure to oxidant drug
• Drugs like Antimalarial, Analgesics, Antipyretics and sulpha
aggravates the conditions (denature protein RBC- Heinz
body)
• Fava beans also have similar effect
Wernicke Korsakoff Syndrome
• Genetic disorder associated with HMP shunt
• Variant form of Transketolase.
• Genetic alteration in Transketolase ,
reduces its affinity with TPP
• Symptoms are
• Mental disorders
• Severe memory loss
• Partial paralysis
Comparison of two pathways
EMP pathway
• Occurs in all tissue
• Not a multi cyclic pathway
• NAD + acts as H acceptor
• ATP is generated
• CO2 is not produced
HMP pathway
• Occurs only in specific tissue
• Involves multi cyclic steps
• NADP+ acts as H acceptor
• ATP is not produced
• CO2 is produced by oxidative
decarboxylation

Class 6 hmp pathway

  • 1.
    Pentose phosphate pathway Putconfidence in GOD and get what he gives Put confidence in self and obtained what you want
  • 2.
    Objectives - Gluconeogenesis •Definition • Other names • Occurrence and tissue distribution • Biomedical importance • Metabolic pathway • Clinical correlations • Regulation • Difference between EMP and HMP pathway
  • 3.
    Definition : Hexose monophosphate pathway • Direct / alternate oxidative pathway for oxidative decarboxylation of glucose-6-phosphate at C-1, producing pentose sugars and NADPH + H+ • It is not involved in the generation of energy
  • 4.
    Other names forpentose phosphate pathway • Hexose monophosphate pathway / shunt • Phosphogluconate pathway • Pentose phosphate cycle • Warburg -Dikens - Lipman pathway About 10% of glucose / day oxidised by this pathway
  • 5.
    Location of thepathway • The enzymes of HMP shunt are located in the cytosol • Tissue actively participating are • Liver and Erythrocyte (30%) • Adipose tissue • Lactating mammary gland • Thyroid gland • Testes and • Adrenal cortex • Most of these tissue are involved in fatty acid and steroid synthesis and depends on NADPH
  • 6.
    Overview of theshunt pathway • It has two phases • Oxidative phase • Glucose 6 phosphate is oxidised to generate two molecules of NADPH with liberation of one CO2 • Non oxidative phase • Pentose phosphate is converted to intermediates of glycolysis
  • 7.
    Significance of HMPshunt • It has two main functions – provides • NADPH • Pentoses • These are utilized by other synthetic pathways
  • 8.
    Importance of NADPH •Required for the biosynthesis of fatty acid, cholesterol, steroids. • Utilized in synthesis of certain amino acids involving glutamate dehydrogenase • Detoxification of drug and foreign compound by Cyt P450 need NADPH
  • 9.
    Importance of NADPH •Required for the process of phagocytosis • Essential for maintaining integrity of RBC membrane and iron in ferrous state • Required for maintaining glutathione in reduced form
  • 10.
    Importance of Pentoses •Converts pentose to hexose, tetrose, triose • Provides glycerol for TAG synthesis • Important for synthesis of Nucleic acid DNA & RNA • Synthesis of Nucleotides –ATP,NAD, FAD, CoA which acts as coenzymes and energy
  • 11.
    1 – OxidativePhase Glucose 6 Phosphate 6 Phosphogluconolactone 6 Phosphogluconate Glucose 6 Phosphate dehydrogenase 6 Phospho gluconolactonase NADP+ NADPH + H+ H2O Mg+2 • Reducing equivalent NADPH are generated • G6PDH is allosteric enzyme hence this is rate limiting step
  • 12.
    6 Phosphogluconate 3-Keto-6-Phosphogluconate D Ribulose5 Phosphate 6 Phosphogluconate Dehydrogenase NADP + NADP H + H+ CO2 Mg +2 • 3-Keto -6 – Phospho gluconate is spontaneously decrboxylated to Ribulose 5 phosphate • C-1 is eliminated as CO2, One more NADPH is produced 1 – Oxidative Phase
  • 13.
    Phase 2 Nonoxidative phase Inter conversion of pentoses Ribulose 5 Phosphate Ribulose 5 Phosphate Ribulose 5 Phosphate Ribose 5 Phosphate Xylulose 5 Phosphate Xylulose 5 Phosphate Phospho pentose Isomerase Phospho pentose Epimerase Phospho pentose Epimerase 3 Ribulose 5 Phosphate
  • 14.
    Phase 2 –Non oxidative phase • In this phase inter conversion of pentose to triose, tetrose, hexose and heptose takes place • Two specific enzymes required • 1. Transketolase – ( Thiamine pyrophosphate required as coenzyme) • 2. Transaldolase
  • 15.
    Xylulose 5 Phosphate Xylulose 5 PhosphateRibulose5 Phosphate Phase 2 -- Non oxidative Steps conversion of pentoses to hexoses Glyceraldehyde 3 Phosphate Sedoheptulose 7 Phosphate Fructose 6 Phosphate Erythrose 4 Phosphate Transketolase Transaldolase TPP Glucose 6 Phosphate Transketolase Fructose 6 Phosphate Glyceraldehyde 3 Phosphate TPP Glucose 6
  • 16.
  • 18.
    In short HMPshunt • When started with six molecules of glucose, • Gives off 6 CO2 , 12 molecules of NADPH and 5 molecules of glucose regenerated • Complete oxidation of glucose 6 phosphate without involvement of mitochondria
  • 19.
    Regulation of HMPshunt • Occurs in 3 ways: • 1. Ratio of [NADP]/[NADPH] , • G6PDH is rate limiting enzyme , it require NADP hence increase level of NADPH decreases reaction Insulin activates G6PDH enzyme • 2. High carbohydrate increases availability of glucose and hence increases HMP shunt and help lipogenesis • Fasting decreases this pathway
  • 20.
    Regulation of HMPshunt • 3. Insulin and thyroid hormone favours reaction • Thus increase BGL increases insulin and increases HMP reactions • Insulin favours lipogenesis and uses NADPH thus increases NADP thereby increases HMP shunt
  • 21.
    Clinical correlations • Deficiencyof Glucose 6 Phosphate dehydrogenase (G6PDH) leads to • Haemolytic Anaemia • Neonatal Jaundice • Liver cirrhosis • Kidney failure
  • 22.
    G6PDH & Haemolysis •Due to deficiency of G6PDH, production of NADPH decreases, • NADPH is required for keeping Glutathione in its reduced form • Reduced Glutathione scavenges Free oxygen radical (ROS) • Deficiency leads to accumulation of methemoglobin and H2O2 • This damages RBC cell membrane and causes Haemolysis
  • 23.
    H2O2 H2O 2 GSH G-S-S-G Reduced glutathione Oxidisedglutathione Glutathione peroxidase Glutathione reductase NADP+ NADPH + H+ Detoxication of hydrogen peroxide and Maintaining reduced glutathione
  • 24.
    G6PDH & Haemolysis •Most of the patients with G6PD deficiency do not show any clinical symptoms but develop haemolytic anaemia & jaundice on exposure to oxidant drug • Drugs like Antimalarial, Analgesics, Antipyretics and sulpha aggravates the conditions (denature protein RBC- Heinz body) • Fava beans also have similar effect
  • 25.
    Wernicke Korsakoff Syndrome •Genetic disorder associated with HMP shunt • Variant form of Transketolase. • Genetic alteration in Transketolase , reduces its affinity with TPP • Symptoms are • Mental disorders • Severe memory loss • Partial paralysis
  • 26.
    Comparison of twopathways EMP pathway • Occurs in all tissue • Not a multi cyclic pathway • NAD + acts as H acceptor • ATP is generated • CO2 is not produced HMP pathway • Occurs only in specific tissue • Involves multi cyclic steps • NADP+ acts as H acceptor • ATP is not produced • CO2 is produced by oxidative decarboxylation